Matches in Wikidata for { <http://www.wikidata.org/entity/Q95838839> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q95838839 description "article scientifique publié en 2020" @default.
- Q95838839 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q95838839 description "im Mai 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q95838839 description "scientific article published on 20 May 2020" @default.
- Q95838839 description "wetenschappelijk artikel" @default.
- Q95838839 description "наукова стаття, опублікована 20 травня 2020" @default.
- Q95838839 name "Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary" @default.
- Q95838839 name "Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary" @default.
- Q95838839 type Item @default.
- Q95838839 label "Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary" @default.
- Q95838839 label "Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary" @default.
- Q95838839 prefLabel "Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary" @default.
- Q95838839 prefLabel "Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary" @default.
- Q95838839 P1433 Q95838839-B9FD1F22-77D1-4FEF-BA04-A5E9A4FF80A3 @default.
- Q95838839 P1476 Q95838839-C02C7FD7-72DB-463B-95C7-E60BB98F87F7 @default.
- Q95838839 P2093 Q95838839-1109D0D3-3ADA-46DB-80F0-17A5DCA38389 @default.
- Q95838839 P2093 Q95838839-186ACAD3-64F1-4F8A-BE25-C5B4B0849A3D @default.
- Q95838839 P2093 Q95838839-18DD1EAD-6655-41FE-B3B4-4CFA5F01FB67 @default.
- Q95838839 P2093 Q95838839-8E593EFC-933E-4597-9076-39D3BC846A3C @default.
- Q95838839 P2093 Q95838839-BAD43127-05FE-4292-924E-054803519E14 @default.
- Q95838839 P2093 Q95838839-CDD40031-E5B8-4807-9D39-07F0BCD86160 @default.
- Q95838839 P2093 Q95838839-DE312DE3-430F-4D8D-9E1B-17BE73A179EA @default.
- Q95838839 P31 Q95838839-29FEF3E6-1C1D-4144-9353-4E3EA0FA4EFD @default.
- Q95838839 P577 Q95838839-CA320227-B055-48DB-89FB-40B8D6570D3A @default.
- Q95838839 P698 Q95838839-9B24D26A-ECB4-4CC0-B202-2B3F0891AAB1 @default.
- Q95838839 P921 Q95838839-A7F8A530-0A65-4062-9E34-09AC2CDF7D97 @default.
- Q95838839 P698 32452349 @default.
- Q95838839 P1433 Q15759225 @default.
- Q95838839 P1476 "Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary" @default.
- Q95838839 P2093 "Elisabetta Greco" @default.
- Q95838839 P2093 "Giulia Lavinia Fonti" @default.
- Q95838839 P2093 "Laura Boffa" @default.
- Q95838839 P2093 "Maria Sole Chimenti" @default.
- Q95838839 P2093 "Paola Conigliaro" @default.
- Q95838839 P2093 "Paola Triggianese" @default.
- Q95838839 P2093 "Roberto Perricone" @default.
- Q95838839 P31 Q13442814 @default.
- Q95838839 P577 "2020-05-20T00:00:00Z" @default.
- Q95838839 P698 "32452349" @default.
- Q95838839 P921 Q52849 @default.